J&J's Ortho enjoined
Executive Summary
From the sale of "any female contraceptive product containing the chemical compound norgestimate" by a Philadelphia federal court pending a full trial or the expiration of American Home Products' patent on norgestrel on Jan. 11, 1994. The Nov. 25 decision came the day before the expiration of another AHP patent on norgestrel, and at the end of a Feb. 23, 1990 injunction that prevented Ortho from selling any norgestimate-containing products because Ortho's Ortho-Cyclen was found to infringe AHP's patent ("The Pink Sheet" March 5, 1990, T&G-10). The current decision holds that Ortho's product infringes a clause of a later AHP patent covering the use of norgestrel.